In other disorders characterized by abnormal complement regulation (i.e. aHUS and AMD), it has been shown that mutations or uncommon SNPs of complement regulatory proteins, such as FH and MCP, generate a state of haploinsufficiency unable to prevent complement mediated tissue damage [41–44]. This evidence concerns the gene CD46 and atypical hemolytic-uremic syndrome.